These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1453 related items for PubMed ID: 9406705

  • 1. Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts.
    Ning S, Trisler K, Wessels BW, Knox SJ.
    Cancer; 1997 Dec 15; 80(12 Suppl):2519-28. PubMed ID: 9406705
    [Abstract] [Full Text] [Related]

  • 2. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
    Behr TM, Béhé M, Stabin MG, Wehrmann E, Apostolidis C, Molinet R, Strutz F, Fayyazi A, Wieland E, Gratz S, Koch L, Goldenberg DM, Becker W.
    Cancer Res; 1999 Jun 01; 59(11):2635-43. PubMed ID: 10363986
    [Abstract] [Full Text] [Related]

  • 3. Intratumoral radioimmunotherapy of a human colon cancer xenograft using a sustained-release gel.
    Ning S, Trisler K, Brown DM, Yu NY, Kanekal S, Lundsten MJ, Knox SJ.
    Radiother Oncol; 1996 May 01; 39(2):179-89. PubMed ID: 8735485
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Local hyperthermia and SR 4233 enhance the antitumor effects of radioimmunotherapy in nude mice with human colonic adenocarcinoma xenografts.
    Wilder RB, Langmuir VK, Mendonca HL, Goris ML, Knox SJ.
    Cancer Res; 1993 Jul 01; 53(13):3022-7. PubMed ID: 8319209
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Overcoming the nephrotoxicity of radiometal-labeled immunoconjugates: improved cancer therapy administered to a nude mouse model in relation to the internal radiation dosimetry.
    Behr TM, Sharkey RM, Sgouros G, Blumenthal RD, Dunn RM, Kolbert K, Griffiths GL, Siegel JA, Becker WS, Goldenberg DM.
    Cancer; 1997 Dec 15; 80(12 Suppl):2591-610. PubMed ID: 9406714
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Determinants of the antitumor effect of radiolabeled monoclonal antibodies.
    Knox SJ, Levy R, Miller RA, Uhland W, Schiele J, Ruehl W, Finston R, Day-Lollini P, Goris ML.
    Cancer Res; 1990 Aug 15; 50(16):4935-40. PubMed ID: 2379158
    [Abstract] [Full Text] [Related]

  • 12. Targeting and therapy of human glioma xenografts in vivo utilizing radiolabeled antibodies.
    Williams JA, Wessels BW, Edwards JA, Kopher KA, Wanek PM, Wharam MD, Order SE, Klein JL.
    Cancer Res; 1990 Feb 01; 50(3 Suppl):974s-979s. PubMed ID: 2404587
    [Abstract] [Full Text] [Related]

  • 13. Combined modality radioimmunotherapy with Taxol and 90Y-Lym-1 for Raji lymphoma xenografts.
    O'Donnell RT, DeNardo SJ, Miers LA, Kukis DL, Mirick GR, Kroger LA, DeNardo GL.
    Cancer Biother Radiopharm; 1998 Oct 01; 13(5):351-61. PubMed ID: 10851425
    [Abstract] [Full Text] [Related]

  • 14. Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re.
    Brouwers AH, van Eerd JE, Frielink C, Oosterwijk E, Oyen WJ, Corstens FH, Boerman OC.
    J Nucl Med; 2004 Feb 01; 45(2):327-37. PubMed ID: 14960657
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Therapy with unlabeled and 131I-labeled pan-B-cell monoclonal antibodies in nude mice bearing Raji Burkitt's lymphoma xenografts.
    Buchsbaum DJ, Wahl RL, Normolle DP, Kaminski MS.
    Cancer Res; 1992 Dec 01; 52(23):6476-81. PubMed ID: 1423295
    [Abstract] [Full Text] [Related]

  • 17. Advantage of yttrium-90-labeled over iodine-131-labeled monoclonal antibodies in the treatment of a human lung carcinoma xenograft.
    Stein R, Chen S, Haim S, Goldenberg DM.
    Cancer; 1997 Dec 15; 80(12 Suppl):2636-41. PubMed ID: 9406718
    [Abstract] [Full Text] [Related]

  • 18. Fractionated radioimmunotherapy of human colon carcinoma xenografts with 131I-labeled monoclonal antibody CC49.
    Buchsbaum D, Khazaeli MB, Liu T, Bright S, Richardson K, Jones M, Meredith R.
    Cancer Res; 1995 Dec 01; 55(23 Suppl):5881s-5887s. PubMed ID: 7493364
    [Abstract] [Full Text] [Related]

  • 19. Comparison of systemic radiotherapy with I-131-labeled monoclonal antibody BW575/9 to external beam radiotherapy in human neuroblastoma xenografts.
    Sautter-Bihl ML, Wessely R, Bihl H.
    Strahlenther Onkol; 1993 Oct 01; 169(10):595-600. PubMed ID: 8235984
    [Abstract] [Full Text] [Related]

  • 20. Reconciliation of tumor dose response to external beam radiotherapy versus radioimmunotherapy with 131iodine-labeled antibody for a colon cancer model.
    Roberson PL, Buchsbaum DJ.
    Cancer Res; 1995 Dec 01; 55(23 Suppl):5811s-5816s. PubMed ID: 7493351
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 73.